Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Papuan Nut (Areca catechu) contains bioactive alkaloids including arecoline, which acts as an α7 nicotinic acetylcholine receptor agonist to modulate inflammation and cellular pathways. Despite traditional use, it poses significant safety risks including oral submucous fibrosis and potential carcinogenic effects.
Reported Benefits (Provisional)
Origin & History
The Papuan Nut, Canarium indicum, is native to the tropical rainforests of Papua New Guinea and other Pacific Islands. It thrives in biodiverse ecosystems, serving as a vital food source for indigenous communities. This nutrient-dense nut is prized for its unique fatty acid profile and potent bioactive compounds.
Research Narrative (Provisional)
Emerging research on the Papuan Nut highlights its rich profile of omega fatty acids, tocopherols, and polyphenols, suggesting benefits for cognitive health, cardiovascular support, and anti-inflammatory action. Further clinical studies are needed to fully elucidate its therapeutic potential in humans.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: Oleic acid (monounsaturated fat), Omega fatty acids - Vitamins: Tocopherols (Vitamin E complex) - Minerals: Magnesium, Potassium, Phosphorus - Phytochemicals: Polyphenols, Flavonoids, Ellagic acid, Catechins, Plant sterols
Reported Mechanism (Provisional)
Arecoline, the primary alkaloid, acts as an α7 nicotinic acetylcholine receptor agonist to inhibit inflammation while activating L-type calcium channels to boost testicular hormone production via 17β-hydroxysteroid dehydrogenase. Epicatechin provides antioxidant activity by scavenging DPPH and hydroxyl radicals (EC50 0.409 mg/mL and 0.188 mg/mL respectively) and inhibits ACE for anti-hypertensive effects. Polyphenols inhibit MAPK pathways and activate Nrf2/HO-1 to reduce reactive oxygen species in inflammatory conditions.
Clinical Narrative (Provisional)
Current evidence is limited to preclinical studies with no published randomized controlled trials in humans. Animal studies show hypolipidemic effects with 0.5% areca nut aqueous methanol extract reducing ACAT and pCEase activity in rats. In vitro studies demonstrate polysaccharide fractions reducing nitric oxide (IC50 85.64 mg/mL) and free radical activity at 2 mg/mL concentrations. Human clinical trials are urgently needed to establish safety and efficacy profiles before therapeutic recommendations can be made.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.